Matrix metalloproteinases and TIMP in acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 2, 1996, Pages 346-352

  Ricou, Bara ^a   Nicod, Laurent ^b   Lacraz, Sylvie ^b   Welgus, Howard G ^b   Suter, Peter M ^b   Dayer, Jean Michel ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GELATINASE; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTENSIVE CARE; LUNG INJURY; LUNG LAVAGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RISK FACTOR; SEPTIC SHOCK; STATISTICAL ANALYSIS;

EID: 0029763303     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.2.8756805     Document Type: Article

References (34)

1. Campbell, E. J., R. M. Senior, and H. G. Welgus. 1987. Extracellular matrix injury during lung inflammation. Chest 92:161-167.
2. Matrisian, L. M. 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:121-125.
3. Woessner, J. F., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.
4. Wilhelm, S. M., I. E. Collier, B. L. Marmer, A. Z. Eisen, G. A. Grant, and G. I. Goldberg. 1989. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:17213-17221.
5. Murphy, G., and A. J. P. Docherty. 1992. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7:120-125.
6. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, and H. G. Welgus. 1991. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J. Immunol. 146:2724-2729.
7. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi , and H. G. Welgus. 1990. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-γ. J. Clin. Invest. 86:1204-1210.
8. Lacraz, S., L. Nicod, B. Galve-de Rochemonteix, C. Baumberger, J. M. Dayer, and H. G. Welgus. 1992. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90:383-388.
9. Kerr, L. D., D. B. Miller, and L. M. Matrisian. 1990. TGF-β inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61:267-278.
10. Arend, W. P., and J. M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 38:151-160.
11. Xing, Z., M. Jordana, and J. Gauldie. 1992. IL-1β and IL-6 gene expression in alveolar macrophages: modulation by extracellular matrices. Am. J. Physiol. 262:L600-605.
12. Welgus, H. G., E. J. Campbell, Z. Bar-Shavit, R. M. Senior, and S. L. Teitelbaum. 1985. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J. Clin. Invest. 76:219-224.
13. Lotz, M., and P. A. Guerne. 1991. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 266:2017-2020.
14. Tetley, T. D. 1993. Proteinase imbalance: its role in lung disease. Thorax 48:560-565.
15. Pardo, A., M. Selman, R. Ramirez, C. Ramos, M. Montano, G. Stricklin, and G. Raghu. 1992. Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest 102:1085-1089.
16. Hudson, L. D., J. A. Milberg, D. Anardi, and R. J. Maunder. 1995. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:293-301.
17. Morel, D. R., F. Dargent, M. Bachmann, P. M. Suter, and A. F. Junod. 1985. Pulmonary extraction of serotonin and propranolol in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132: 479-484.
18. Ricou, B., St. Grandin, L. Nicod, J. B. Thorens, and P. M. Suter. 1995. Adult and pediatric size bronchoscopes for bronchoalveolar lavage in mechanically ventilated patients: yield and side effects. Thorax 50: 290-293.
19. Bergmann, U., J. Michaelis, R. Oberhoff, V. Knäuper, R. Beckmann, and H. Tschesche. 1989. Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. J. Clin. Chem. Clin. Biochem. 27:351-359.
20. Welgus, H. G., and G. P. Stricklin. 1983. Human skin fibroblast collagenase inhibitor: Comparative studies in human connective tissues, serum and amniotic fluid. J. Biol. Chem. 258:12259-12264.
21. O'Connor, C. M. O., and M. X. FitzGerald. 1994. Matrix metalloproteases and lung disease. Thorax 49:602-609.
22. Cooper, T. W., G. P. Stricklin, A. Z. Eisen, and H. G. Welgus. 1985. Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc. Natl. Acad. Sci. U.S.A. 82:2779-2784.
23. Hirose, T., R. A. Reife, G. N. Smith, Jr., R. M. Stevens, C. L. Mainardi, and K. A. Hasty. 1992. Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J. Rheumatol. 19:593-599.
24. Palmgren, M. S., R. D. De Shazo, R. M. Carter, M. L. Zimmy, and S. V. Shah. 1992. Mechanisms of neutrophil damage to human alveolar extracellular matrix: the role of serine and metalloproteinases. J. Allergy Clin. Immunol. 89:905-915.
25. Clark, J. G., J. A. Milberg, K. P. Steinberg, and L. D. Hudson. 1995. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann. Intern. Med. 122:17-23.
26. 2 removal. Eur. J. Clin. Chem. Clin. Biochem. 29:805-812.
27. Martinet, Y., W. N. Rom, G. R. Grotendorst, G. R. Martin, and R. G. Crystal. 1987. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 317:202-209.
28. Emonard, H., and J. A. Grimaud. 1990. Matrix metalloproteinases: a review. Cell. Mol. Biol. 36:131-152.
29. Border, W. A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Ivest. 90:1-7.
30. Lacraz, S., P. Isler, E. Vey, H. G. Welgus, and J. M. Dayer. 1994. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269:22027-22033.
31. Miltenburg, A. M. M., A. Lacraz, H. G. Welgus, and J. M. Dayer. 1995. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J. Immunol. 154:2655-2667.
32. Seed, M. P., S. Ismaiel, C. Y. Cheung, T. A. Thomson, C. R. Gardner, R. M. Atkins, and C. J. Elson. 1993. Inhibition of interleukin-1β induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391. Ann. Rheum. Dis. 52:37-43.
33. Rudolphus, A., J. Stolk, J. H. Dijkman, and J. A. Kramps. 1993. Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am. Rev. Respir. Dis. 147:442-447.
34. Meduri, G. U., A. J. Chinn, K. V. Leeper, R. G. Wunderink, E. Tolley, H. T. Winer-Muram, V. Kare, and M. Eltorky. 1994. Coticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 105:1516-1527.